down arrow

Mankind Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,340.80
10.45 (0.45%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.22 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

2,318.002,381.00

52 Week

1,910.103,050.00
Valuation
Technical
Day's Volume

CASH

1.22 lacs (-61.53%) Volume

Shareholding (Dec 2024)

FII

13.35%

Held by 537 FIIs

DII

11.02%

Held by 30 DIIs

Promoter

72.71%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

The company has declared negative results in Dec 24 after 6 consecutive negative quarters

  • PAT(Q) At Rs 380.23 cr has Fallen at -28.1 %
  • INTEREST(Q) At Rs 220.93 cr has Grown at 3,011.69 %
  • OPERATING PROFIT TO INTEREST (Q) Lowest at 3.76 times
2

Stock is technically in a Bearish range

3

With ROE of 20, it has a Very Expensive valuation with a 9.1 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 96,576 Cr (Large Cap)

stock-summary
P/E

47.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.40

stock-summary
Return on Equity

20.02%

stock-summary
Price to Book

9.10

Revenue and Profits (1 Year):
Net Sales:
3,230 Cr
(Quarterly Results - Dec 2024)
Net Profit:
380 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-16.07%
0%
-16.07%
1 Year
-1.14%
0%
-1.14%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Mankind Pharma for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
18.50%
EBIT Growth (5y)
11.80%
EBIT to Interest (avg)
35.25
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.06
Tax Ratio
20.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.37%
ROCE (avg)
30.29%
ROE (avg)
19.25%
Valuation key factors
Factor
Value
P/E Ratio
47
Industry P/E
33
Price to Book Value
9.10
EV to EBIT
37.63
EV to EBITDA
31.12
EV to Capital Employed
14.54
EV to Sales
7.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
36.42%
ROE (Latest)
20.02%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 30 Schemes (7.97%)

FIIs

Held by 537 FIIs (13.35%)

Promoter with highest holding

Ramesh Juneja Family Trust (held In The Name Of Ramesh Juneja, Managing Trustee) (20.2%)

Highest Public shareholder

Sbi Nifty 500 Index Fund (1.67%)

Individual Investors Holdings

1.62%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 4.99% vs 6.33% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -41.81% vs 21.80% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,230.00",
          "val2": "3,076.51",
          "chgp": "4.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "829.80",
          "val2": "850.04",
          "chgp": "-2.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "220.93",
          "val2": "7.10",
          "chgp": "3,011.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "380.23",
          "val2": "653.47",
          "chgp": "-41.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.69%",
          "val2": "27.63%",
          "chgp": "-1.94%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 12.92% vs 14.78% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 20.45% vs 38.70% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,969.93",
          "val2": "5,286.72",
          "chgp": "12.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,531.80",
          "val2": "1,337.46",
          "chgp": "14.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.01",
          "val2": "14.96",
          "chgp": "20.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,189.96",
          "val2": "987.90",
          "chgp": "20.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.66%",
          "val2": "25.30%",
          "chgp": "0.36%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 16.55% vs 17.87% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.92% vs 44.68% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,199.93",
          "val2": "7,893.67",
          "chgp": "16.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,361.60",
          "val2": "1,943.96",
          "chgp": "21.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "238.94",
          "val2": "24.15",
          "chgp": "889.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,570.19",
          "val2": "1,441.66",
          "chgp": "8.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.67%",
          "val2": "24.63%",
          "chgp": "1.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 18.12% vs 12.44% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 49.23% vs -10.58% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,334.77",
          "val2": "8,749.43",
          "chgp": "18.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,535.06",
          "val2": "1,900.63",
          "chgp": "33.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "33.53",
          "val2": "44.47",
          "chgp": "-24.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,912.90",
          "val2": "1,281.86",
          "chgp": "49.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.53%",
          "val2": "21.72%",
          "chgp": "2.81%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
3,230.00
3,076.51
4.99%
Operating Profit (PBDIT) excl Other Income
829.80
850.04
-2.38%
Interest
220.93
7.10
3,011.69%
Exceptional Items
0.00
0.00
Consolidate Net Profit
380.23
653.47
-41.81%
Operating Profit Margin (Excl OI)
25.69%
27.63%
-1.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 4.99% vs 6.33% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -41.81% vs 21.80% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
5,969.93
5,286.72
12.92%
Operating Profit (PBDIT) excl Other Income
1,531.80
1,337.46
14.53%
Interest
18.01
14.96
20.39%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,189.96
987.90
20.45%
Operating Profit Margin (Excl OI)
25.66%
25.30%
0.36%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 12.92% vs 14.78% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 20.45% vs 38.70% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
9,199.93
7,893.67
16.55%
Operating Profit (PBDIT) excl Other Income
2,361.60
1,943.96
21.48%
Interest
238.94
24.15
889.40%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,570.19
1,441.66
8.92%
Operating Profit Margin (Excl OI)
25.67%
24.63%
1.04%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 16.55% vs 17.87% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 8.92% vs 44.68% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
10,334.77
8,749.43
18.12%
Operating Profit (PBDIT) excl Other Income
2,535.06
1,900.63
33.38%
Interest
33.53
44.47
-24.60%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,912.90
1,281.86
49.23%
Operating Profit Margin (Excl OI)
24.53%
21.72%
2.81%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 18.12% vs 12.44% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 49.23% vs -10.58% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Mankind Pharma Ltd stock-summary
stock-summary
Mankind Pharma Ltd
Large Cap
Pharmaceuticals & Drugs
Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name "Mankind Pharma Private Limited", by the Registrar of Companies, Delhi and Haryana, at New Delhi. Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to "Mankind Pharma Limited" and the RoC issued a fresh Certificate of Incorporation on April 13, 2006.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."